Inhalable exosomes outperform liposomes as mRNA and protein drug carriers to the lung
Respiratory diseases are among the leading causes of morbidity and mortality worldwide, coupled with the ongoing coronavirus disease 2019 (COVID-19) pandemic. mRNA lipid nanoparticle (LNP) vaccines have been developed, but their intramuscular delivery limits pulmonary bioavailability. Inhalation of...
| 發表在: | Extracellular Vesicle |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Elsevier
2022-12-01
|
| 主題: | |
| 在線閱讀: | http://www.sciencedirect.com/science/article/pii/S2773041722000014 |
